Elemental Impurities in Drug Products

Detalhes bibliográficos
Autor(a) principal: Brovchenko, Iryna
Data de Publicação: 2019
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/89661
Resumo: Elemental Impurities are traces of metals found in medicines, originating from different sources in the product life cycle. ICH has developed the Q3D guideline for 24 Elemental Impurities, divided into 3 classes, based on toxicity and occurrence. Currently, this guideline limits these elements to oral, inhalation and parenteral routes of administration and does not cover the topical route. Initially, it was intended to establish the permitted daily exposure to the topical route, for risk analysis to various pharmaceutical products in order to find those that appeared to be at higher risk for later analysis in the ICP-AES. The risk from the primary packaging material, with subsequent laboratory testing, and a utility (purified water) was also assessed. One of the samples for the analysis was submitted to the digestion process and before the analysis the ICP-AES validation was performed. In the risk analyses it was found that the drugs were below the permitted daily exposure, and that there was one same excipient in the composition of several worst-case products. The greatest risk due to uncertainty was found for one oral solution and two semi-solid products. The analytical method was validated for selectivity, accuracy, linearity, precision, limit of detection and quantification for the 24 elements and proved to be adequate. The detection and quantification limits obtained were optimistic, for example, nickel has a detection and quantification limit of 0.00124 ppm and 0.00375 ppm, respectively. With the ICP-AES it was found that the excipient selected has in its composition Elemental Impurities higher than those accepted in European standards which allows us to conclude that this excipient is one of the main sources of Elemental Impurities for the drugs to which it belongs. There was also a risk associated with semisolid product tubes which yielded arsenic (1.20340 ppm), selenium (0.77105 ppm) and tin (1.15530 ppm).
id RCAP_f79c3ae63e90afda1de8ee2f183495a6
oai_identifier_str oai:run.unl.pt:10362/89661
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Elemental Impurities in Drug ProductsElemental impuritiesrisk assessmentFMEAICHQ3DICP-AESDomínio/Área Científica::Engenharia e Tecnologia::Engenharia QuímicaElemental Impurities are traces of metals found in medicines, originating from different sources in the product life cycle. ICH has developed the Q3D guideline for 24 Elemental Impurities, divided into 3 classes, based on toxicity and occurrence. Currently, this guideline limits these elements to oral, inhalation and parenteral routes of administration and does not cover the topical route. Initially, it was intended to establish the permitted daily exposure to the topical route, for risk analysis to various pharmaceutical products in order to find those that appeared to be at higher risk for later analysis in the ICP-AES. The risk from the primary packaging material, with subsequent laboratory testing, and a utility (purified water) was also assessed. One of the samples for the analysis was submitted to the digestion process and before the analysis the ICP-AES validation was performed. In the risk analyses it was found that the drugs were below the permitted daily exposure, and that there was one same excipient in the composition of several worst-case products. The greatest risk due to uncertainty was found for one oral solution and two semi-solid products. The analytical method was validated for selectivity, accuracy, linearity, precision, limit of detection and quantification for the 24 elements and proved to be adequate. The detection and quantification limits obtained were optimistic, for example, nickel has a detection and quantification limit of 0.00124 ppm and 0.00375 ppm, respectively. With the ICP-AES it was found that the excipient selected has in its composition Elemental Impurities higher than those accepted in European standards which allows us to conclude that this excipient is one of the main sources of Elemental Impurities for the drugs to which it belongs. There was also a risk associated with semisolid product tubes which yielded arsenic (1.20340 ppm), selenium (0.77105 ppm) and tin (1.15530 ppm).Vaz, RitaEusébio, MárioRUNBrovchenko, Iryna2022-09-17T00:31:00Z2019-11-2520192019-11-25T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/89661enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:39:56Zoai:run.unl.pt:10362/89661Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:37:03.037396Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Elemental Impurities in Drug Products
title Elemental Impurities in Drug Products
spellingShingle Elemental Impurities in Drug Products
Brovchenko, Iryna
Elemental impurities
risk assessment
FMEA
ICH
Q3D
ICP-AES
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
title_short Elemental Impurities in Drug Products
title_full Elemental Impurities in Drug Products
title_fullStr Elemental Impurities in Drug Products
title_full_unstemmed Elemental Impurities in Drug Products
title_sort Elemental Impurities in Drug Products
author Brovchenko, Iryna
author_facet Brovchenko, Iryna
author_role author
dc.contributor.none.fl_str_mv Vaz, Rita
Eusébio, Mário
RUN
dc.contributor.author.fl_str_mv Brovchenko, Iryna
dc.subject.por.fl_str_mv Elemental impurities
risk assessment
FMEA
ICH
Q3D
ICP-AES
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
topic Elemental impurities
risk assessment
FMEA
ICH
Q3D
ICP-AES
Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química
description Elemental Impurities are traces of metals found in medicines, originating from different sources in the product life cycle. ICH has developed the Q3D guideline for 24 Elemental Impurities, divided into 3 classes, based on toxicity and occurrence. Currently, this guideline limits these elements to oral, inhalation and parenteral routes of administration and does not cover the topical route. Initially, it was intended to establish the permitted daily exposure to the topical route, for risk analysis to various pharmaceutical products in order to find those that appeared to be at higher risk for later analysis in the ICP-AES. The risk from the primary packaging material, with subsequent laboratory testing, and a utility (purified water) was also assessed. One of the samples for the analysis was submitted to the digestion process and before the analysis the ICP-AES validation was performed. In the risk analyses it was found that the drugs were below the permitted daily exposure, and that there was one same excipient in the composition of several worst-case products. The greatest risk due to uncertainty was found for one oral solution and two semi-solid products. The analytical method was validated for selectivity, accuracy, linearity, precision, limit of detection and quantification for the 24 elements and proved to be adequate. The detection and quantification limits obtained were optimistic, for example, nickel has a detection and quantification limit of 0.00124 ppm and 0.00375 ppm, respectively. With the ICP-AES it was found that the excipient selected has in its composition Elemental Impurities higher than those accepted in European standards which allows us to conclude that this excipient is one of the main sources of Elemental Impurities for the drugs to which it belongs. There was also a risk associated with semisolid product tubes which yielded arsenic (1.20340 ppm), selenium (0.77105 ppm) and tin (1.15530 ppm).
publishDate 2019
dc.date.none.fl_str_mv 2019-11-25
2019
2019-11-25T00:00:00Z
2022-09-17T00:31:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/89661
url http://hdl.handle.net/10362/89661
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137987624173568